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Abstract
Introduction
Hip arthroplasty is the standard treatment of a painful hip destruction. The use of modern
metal-on-metal (MOM) bearing surfaces gained popularity in total hip arthroplasties during
the last decade. Recently, worrisome failures due to adverse reaction to metal debris
(ARMD), including pseudotumor response, have been widely reported. However, the patho-
genesis of this reaction remains poorly understood. The aim of the present study was to
investigate the ARMD response by flow cytometry approach.
Methods
Sixteen patients with a failed Articular Surface Replacement (ASR) hip prosthesis were
included in the study. Samples of pseudotumor tissues collected during revision surgery were
degraded by enzyme digestion and cells were typed by flow cytometry. Whole blood chromium
and cobalt concentrations were analyzed with mass spectrometry before revision surgery.
Results
Flow cytometry analysis showed that the peri-implant pseudotumor tissue expressed two
principal phenotypes, namely macrophage-dominated and T-lymphocyte-dominated
response; the average portions being 54% (macrophages) and 25% (T-lymphocytes) in
macrophage-dominated inflammation and 20% (macrophages) and 54% (T-lymphocytes)
in T-lymphocyte-dominated response. The percentages of B-lymphocytes and granulocytes
were lower in both phenotypes. Interestingly, the levels of blood chromium and cobalt were
significantly higher in patients with macrophage-dominated response.
Conclusions
The results suggest that the adverse tissue reactions induced by MOM wear particles con-
tain heterogeneous pathogeneses and that the metal levels are an important factor in the
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determination of the inflammatory phenotype. The present results support the hypothesis
that higher metal levels cause cytotoxicity and tissue injury and macrophages are recruited
to clear the necrotic debris. On the other hand, the adverse response developed in associa-
tion with lower metal levels is T-lymphocyte-dominated and is likely to reflect hypersensitiv-
ity reaction.
Introduction
Total hip arthroplasty (THA) is an established and well documented operative treatment of a
painful hip destruction associated with osteoarthritis (OA) or rheumatoid arthritis (RA).
Although the conventional hip arthroplasty has a good reputation, the factor limiting its dura-
bility especially in younger THA patients has been the wear of polyethylene (PE) socket [1,2].
Metal-on-metal articulation (MOM) has been used for decades as a more wear-resistant alter-
native to conventional metal-on-polyethylene bearing in THA [3]. The recent MOM hip boom
was initiated by the encouraging early results obtained using hip resurfacing and THA
implants [4,5]. Most major companies introduced their versions of the resurfacing implant, fol-
lowed by adaptation of MOM bearing surfaces into conventional stemmed THA devices. Early
clinical reports of these second generation MOM hips were promising, and the method was
soon widely used: for example, in the US the proportion of MOM bearing surface was 35% of
total hip arthroplasties in 2005–2006 [6].
Only after several years of routine clinical use of MOM hip implants, reports of failures
started to emerge. It became apparent that in some patients the metal wear debris induces a
local inflammatory reaction, now known as “adverse reaction to metal debris” (ARMD) [7–
10]. Clinical features associated with ARMD and increased failures of MOM hips include sub-
optimal acetabular component positioning [11,12] leading to edge loading and excessive pro-
duction of metal wear particles [13] but the reaction may occur also in perfectly well aligned
implants. Also, the head size of the MOM implant seems to relate to the risk and the incidence
of ARMD has been reported to be higher in females [12,14]. Further, there are clear differences
between the MOM implant designs, the Articular Surface Replacement (ASR) being the one
associated with most frequent ARMD reactions [12,15,16]. The poor performance of ASR
prostheses in the British National Joint Registry prompted a medical device alert by the author-
ities, followed by a voluntary recall of the product by the manufacturer DePuy [17,18].
According to the studies analyzing the cases with a clinical failure of a MOM, ARMD is
widely present regardless of the type of the implant. At the same time, the inflammatory pro-
cess related to the ARMD reaction remains poorly understood in many aspects. Already in
1970s Jones and co-workers reported of fluid-filled capsules and necrotic tissue around metallic
McKee devices [19] mimicking the pseudotumour like reaction seen also in association with
the failure of many modern MOM devices. Histologically, the tissue displays an inflammatory
appearance with cystic and solid masses with tissue debris and inflammatory cells [7,9,20–23].
Macrophages, many of which contain metal particles, are usually seen. Also lymphocytes are
present and they often appear as aggregates around post-capillary venules. This type of histo-
logical appearance is often called aseptic lymphocyte-dominated vasculitis associated lesion
(ALVAL) [7,20]. Prominent lymphocyte infiltration has given rise to a hypothesis that metal
wear particles elicit a delayed-type hypersensitivity reaction [7]. However, the results of epicu-
taneous skin-tests performed to the patients with a failed MOM implant have been contradic-
tory [24] and as described in recent reviews [23,25,26] hypotheses of foreign-body reaction and
cytotoxicity have also been expressed, especially as ALVAL characteristics are not always
found in pseudotumour tissue.
MOMReaction Is Linked to Blood Metal Levels
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The histology of ARMD has been beautifully described [7,20–23,27]. In the present study,
we aimed to have another approach to investigate and understand the cell types and mecha-
nisms involved in ARMD by utilizing flow cytometry to further characterize the tissue reaction
in failed MOM implants using tissue obtained from ASR revisions as an example.
Patients and Methods
Patients
The study was approved by the Ethics Committee of Tampere University Hospital, Tampere,
Finland, and complies with the declaration of Helsinki. All patients provided their written
informed consent.
Pseudotumor tissue from sixteen consecutive revisions of Articular Surface Replacement
(ASR, DePuy, Warsaw, IN, USA) hip arthroplasties carried out at Coxa Hospital for Joint
Replacement, Tampere, Finland were collected and analyzed. The clinical characteristics of the
patients are described in Table 1. All primary operations had been performed for the treatment
of end-stage osteoarthritis.
Reasons for Revision Surgery
Revision surgery of a MOM hip was considered if 1) a thick-walled pseudotumour with atypi-
cal contents or a solid pseudotumour was seen in cross-sectional imaging regardless of symp-
toms and whole blood metal ion levels; or 2) the patient had both elevated metal ion levels and
hip symptoms despite a normal finding on cross-sectional imaging; or 3) increasingly and sig-
nificantly symptomatic hip regardless of imaging findings or metal ion levels [28]. Symptoms
included hip pain, discomfort, sense of instability, and/or impaired function of the hip as well
as sounds from the hip. Infection was ruled out by at least five bacterial cultures obtained dur-
ing revision surgery.
Cell Isolation
Peri-implant tissue was obtained directly from surgery; the necrotic mass was removed and the
tissue was minced and digested fresh with a cocktail of 1 mg/ml of Liberase TM Research
Table 1. Patient Characteristics.
Patient Gender Age (yr) ASR implant type ASR implant in-situ time (months) Reason for revision
1 male 46 ASR XL modular 22 extremely high blood metal ion levels
2 female 49 ASR XL modular 31 extremely high blood metal ion levels
3 female 58 ASR XL modular 30 high blood metal ion levels, pseudotumour
4 male 75 ASR XL modular 39 high blood metal ion levels, pseudotumour, symptoms
5 male 65 ASR XL modular 42 high blood metal ion levels, pseudotumour, symptoms
6 female 54 ASR resurfacing 67 symptoms
7 female 46 ASR XL modular 81 high blood metal ion levels, symptoms
8 female 73 ASR resurfacing 63 high blood metal ion levels, pseudotumour, symptoms
9 male 74 ASR XL modular 43 high blood metal ion levels, pseudotumour, symptoms
10 female 64 ASR resurfacing 85 high blood metal ion levels, pseudotumour
11 female 56 ASR resurfacing 29 high blood metal ion levels, pseudotumour, symptoms
12 male 52 ASR XL modular 62 high blood metal ion levels, symptoms
13 female 63 ASR XL modular 52 moderately elevated blood metal ion levels, symptoms
14 male 67 ASR XL modular 54 high blood metal ion levels, pseudotumour, symptoms
15 female 64 ASR XL modular 76 high blood metal ion levels
16 male 65 ASR XL modular 39 high blood metal ion levels, pseudotumour, symptoms
doi:10.1371/journal.pone.0155121.t001
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Grade (Roche, Mannheim, Germany) and 0.04/0.32 U/ml of Collagenase/Dispase (Roche,
Mannheim, Germany) in RPMI 1640 (Lonza Group Ltd, Basel, Switzerland) supplemented
with penicillin (100 U/ml), streptomycin (100 μg/ml) and amphotericin B (250 ng/ml) (all
from Invitrogen/Life Technologies, Carlsbad, CA, USA) at 37°C for 2 hours. After the diges-
tion, the cell suspension was passaged through a cell strainer, washed three times with cold
phosphate buffered saline (PBS) containing 5% of heat-inactivated foetal bovine serum (FBS)
(Lonza Group Ltd, Basel, Switzerland) and resuspended in PBS supplemented with 5% of FBS
for flow cytometry analysis, or in RPMI 1640 supplemented with 10% of FBS and antibiotics
(see above) for cell culturing.
Cell Characterization by Flow Cytometry
1 x 106 freshly isolated pseudotumor tissue -derived cells were first incubated with purified
human Fc Receptor Binding Inhibitor (eBiosciences, San Diego, CA, USA) for 5 minutes and
then stained with a combination of antibodies against the pan-leukocyte marker CD45
(labelled with fluorescein isothiocyanate, FITC; Becton, Dickinson and Company, Franklin
Lakes, NJ, USA), macrophage marker CD14 (labelled with phycoerythrin Cy7, PE-Cy7; eBios-
ciences), T-lymphocyte marker CD3 (labelled with allophycocyanin Cy7, APC-Cy7; Becton,
Dickinson and Company), B-lymphocyte marker CD19 (labelled with allophycocyanin, APC;
eBiosciences) and pan-granulocyte marker CD15 (labelled with phycoerythrin, PE; Becton,
Dickinson and Company) for 20 minutes. After the incubation, the cells were washed twice
with PBS supplemented with 1% of FBS, fixed with 1% of paraformaldehyde for 10 minutes
and again washed twice with PBS/1% FBS. The samples were examined by FACSCanto II flow
cytometry (Becton, Dickinson and Company) and the data was analyzed using FlowJo software
(Tree Star, Inc, Ashland, OR, USA). In the preliminary experiments both anti-CD14 (see
above) and anti-CD68 (labelled with fluorescein isothiocyanate, FITC; eBiosciences) were used
as macrophage markers; as the results were similar anti-CD14 was chosen for the further
experiments.
Cell Culture
Pseudotumor tissue -derived cells were cultured (in two duplicates per patient) in the density
of 5 x 105 cells/ml in 6-well plates in RPMI 1640 supplemented with 10% of FBS and antibiotics
(see above) at 37°C in humidified 5% CO2 atmosphere. After 42 hours of incubation, the cul-
ture media were collected, the samples were centrifuged at 400 g for 10 minutes and the super-
natants were stored at -20°C until assayed for IL-6 and TNFα.
Enzyme-Linked Immunosorbent Assay (ELISA)
The concentrations of IL-6 and TNFα in the culture media were determined by ELISA using
reagents from R&D Systems Europe, Abingdon, UK and the assays were run in duplicate.
Metal Ion Concentrations
Whole blood samples were collected using twenty-one-gauge needle connected to a Vacutainer
TM system (Becton, Dickinson and Company) and trace element blood tubes containing
sodium ethylenediaminetetraacetic acid. In the Finnish Institute for Occupational Health
(FIOH), standard operating procedures were established for Co and Cr measurement using
dynamic reaction cell inductively coupled plasma (quadripole) mass spectrometry (Agilent
7500 cx, Agilent Technologies, Santa Clara, CA, USA). The FIOH laboratory is accredited and
has been used in several published studies utilizing blood metal ion measurements [28–30].
MOMReaction Is Linked to Blood Metal Levels
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Statistics
Results of normally distributed data are expressed as mean ± standard error of mean (SEM)
and non-normally distributed data as median ± quartile range and range of values as indicated.
Statistical significance of the differences between groups was calculated either by unpaired t-
test (with Welch correction when needed) or by Mann-Whitney test where appropriate. Differ-
ences were considered significant at  = p<0.05,  = p<0.01, and  = p<0.001.
Results
The Distribution of the Inflammatory Cells were Polarized either to
Macrophages or T-Lymphocytes
Inflammatory cells present in the pseudotumour tissue were characterized by flow cytometry.
CD45 antigen was used as a general hematopoietic cell marker. CD14 (confirmed with similar
results with CD68) was used as a marker of macrophages and CD3 and CD19 antigens were
used to identify T-lymphocytes and B-lymphocytes, respectively. CD15 was used as a pan-
granulocyte marker.
Macrophages and T-lymphocytes were the most dominant subsets of CD45+ cells (Table 2).
B-lymphocytes were less frequent than T-lymphocytes, but in four cases the proportion of B-
lymphocytes was more than 10% of all leukocytes, 19.2% being the highest proportion
(Table 2). The proportion of granulocytes was generally low (median 1.78%) and only in one
case it exceeded 5% (Table 2).
Interestingly, most of the samples were clearly dividable into two groups according to their
cell distributions (Fig 1). Seven of the 16 samples displayed macrophage-dominated cell distri-
bution and six of the 16 were T-lymphocyte-dominated. In the macrophage-dominated group,
Table 2. Inflammatory Cell Distributions andWhole Blood Metal Levels.
Proportions of haematopoietic cells (%)
Patient Macro-phages T cells B cells granulo-cytes B-Cr (μg/l) B-Co (μg/l)
1 45.7 27.0 no data 3.03 28.8 64.9
2 51.2 20.7 no data 2.24 36.2 114.3
3 42.7 42.4 0.09 4.01 13.3 14.2
4 30.4 50.2 1.20 2.06 3.5 13.8
5 53.7 29.9 7.25 1.15 20.6 18.7
6 15.0 48.5 8.92 4.90 2.9 2.5
7 30.4 31.8 19.2 1.44 12.2 20.0
8 56.8 15.8 0.05 13.0 45.2 113.3
9 68.4 18.5 0.34 3.54 9.3 22.1
10 43.9 34.9 12.3 0.73 53.5 96.9
11 55.2 27.0 3.07 1.13 11.8 14.2
12 15.7 54.8 6.44 1.00 8.2 13.2
13 16.3 59.3 0.73 1.17 1.3 5.9
14 25.8 54.2 11.5 1.50 2.7 10.7
15 29.4 31.8 0.72 2.15 21.6 36.3
16 18.1 55.1 12.3 0.98 3.3 10.5
B-Cr = whole blood chromium; B-Co = whole blood cobalt
CD45+ cells were deﬁned as hematopoietic cells, CD45+CD14+ as macrophages, CD45+CD3+ as T-lymphocytes (T cells), CD45+CD19+ as B-
lymphocytes (B cells) and CD45+CD15+ as granulocytes.
doi:10.1371/journal.pone.0155121.t002
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the average (mean ± SEM) proportion of macrophages was 53.5 ± 3.0% and that of T-lympho-
cytes 24.8 ± 2.5%. While the corresponding values were 20.2 ± 2.5% (macrophages) and
53.6 ± 1.5% (T-lymphocytes) in the T-lymphocyte-dominated group. There were no overlap-
ping cases in the proportions of either macrophages or T-lymphocytes between the two groups.
The remaining three samples were classified as mixed reaction as they had about equal percent-
age of CD14 and CD3 positive cells. The three groups had comparable percentages of B-lym-
phocytes and granulocytes (Fig 1).
IL-6 and TNFα Production was Elevated in Macrophage-Dominated
Response
Next, we analyzed the IL-6 and TNFα production of the cells derived from pseudotumor tissue.
The cells were cultured for 42 hours and the levels of IL-6 and TNFα were measured in the cul-
ture medium by ELISA. TNFα production was higher in the macrophage-dominated group
than in the T-lymphocyte-dominated group (p<0.05) and IL-6 production showed a similar
trend (p = 0.07) as seen in Fig 2.
Blood Metal Ion Concentrations were Related to the Inflammatory Cell
Distribution in the Pseudotumor Tissue
All of the patients had increased blood metal ion levels with a significant variation between the
patients. The metal ion levels of either blood chromium or cobalt exceeded the action level of
Fig 1. Flow Cytometry Analysis of CD45+ Cells Derived from Pseudotumor Tissue.CD45+ cells were
gated and proportions of CD14+, CD3+, CD15+ and CD19+ cells were analyzed. The cases were divided into
three groups according to CD14+ and CD3+ cell proportions, namely macrophage-dominated (B), T-
lymphocyte-dominated (C) and mixed (D) groups. Average values (mean + SEM) of the proportions of
different cell types in the three different phenotypes of inflammation (A) with representative flow cytometry
blots (B-D) are shown. n = 7 in macrophage-dominated group, n = 6 in T-lymphocyte-dominated group and
n = 3 in mixed group. ***p<0.001
doi:10.1371/journal.pone.0155121.g001
Fig 2. The Production of IL-6 and TNFα by Cells Derived from Pseudotumor Tissue. Samples of pseudotumor tissue were degraded by
enzyme digestion and cell suspensions were cultured for 42 hours. Thereafter IL-6 (A) and TNFα (B) accumulated into the culture medium were
measured by ELISA. Boxplots represent medians and interquartile ranges and whiskers indicate range of values. n = 7 in macrophage-
dominated group, n = 5 in T-lymphocyte-dominated group and n = 3 in mixed group. *p<0.05.
doi:10.1371/journal.pone.0155121.g002
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7 ppb proposed in the Medicines and Healthcare Products Regulatory Agency (MHRA, UK)
guidelines [31] in 14 out of 16 patients. The median (range) of blood chromium concentration
was 12.0 (1.3–53.5) μg/l and the median of blood cobalt level was 16.5 (2.5–114.3) μg/l
(Table 2).
When the levels of blood chromium and cobalt in patients with macrophage or T-lympho-
cyte -dominated inflammatory phenotype were compared, a remarkable difference between
the groups was found. Both the chromium and cobalt levels were significantly higher in
patients with macrophage-dominated inflammation than in the patients with T-lymphocyte-
dominated response with the median levels being 28.8 μg/l (Cr) and 64.9 μg/l (Co) in the mac-
rophage-dominated group and 3.1 μg/l (Cr) and 10.6 μg/l (Co) in the T-lymphocyte-domi-
nated group (Fig 3). The small group of patients with similar macrophage and T-lymphocyte
abundance had median blood chromium level of 13.3 μg/l and cobalt level of 20.0 μg/l.
Discussion
The adverse tissue reactions related to MOM implants are presently a major topic in hip
arthroplasty debates, but the understanding on the detailed cellular mechanisms eventually
resulting in the development of the reaction remains limited and various hypotheses have been
presented [7,20,23–27]. The present study shows that the inflammatory activation related to
failed ASR implants is heterogeneous and can be characterized either as s macrophage or as a
T-lymphocyte dominated reaction. Interestingly, the two types of responses differed also
according to the blood metal ion concentrations in a manner that the macrophage-dominated
phenotype was associated with higher blood levels of chromium and cobalt.
The histology of ARMD has been described in a number of publications, e.g. [7,20–23,27].
The present study extends the previous data by utilizing flow cytometry analysis in the charac-
terization of cell types in the pseudotumor tissue of revised MOM hips. The pseudotumour tis-
sue was degraded by enzyme digestion and the resulting cell suspension was analyzed by flow
Fig 3. The Blood Chromium and Cobalt Levels.Whole blood samples were taken preoperatively from the patients and chromium (A) and
cobalt (B) concentrations were analyzed by inductively coupled plasmamass spectrometry. Boxplots represent medians and interquartile
ranges and whiskers indicate range of values. n = 7 in macrophage-dominated group, n = 5 in T-lymphocyte-dominated group and n = 3 in
mixed group. *p<0.05, **p<0.01
doi:10.1371/journal.pone.0155121.g003
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cytometry. Therefore, results on the cell typing are more representative for the entire pseudotu-
mor tissue reaction than the usual histology which is limited to the sections investigated. Fur-
ther, the flow cytometric data can be analyzed in a more quantitative manner.
Our results show that the leukocyte populations in the ARMD are dominated either by mac-
rophages or by T-lymphocytes but the percentage of the polymorphonuclear leukocytes (i.e.
CD15 positive cells including both neutrophils and eosinophils) remained rather low, the median
being less than 2% of all leukocytes. Eosinophils have sometimes been noted in the histological
studies [7,9] but in the present study we did not specify the granulocyte subtypes. However, the
low percentage of granulocytes suggests that neither direct eosinophil mediated allergic response
nor neutrophil mediated innate immune response plays any major role in the pathogenesis of the
ARMD in most patients. Further, infection was ruled out with multiple bacterial cultures of sam-
ples collected during the revision surgery. Intriguingly, also the percentage of B-lymphocytes was
lower than that of T-lymphocytes in all patients supporting a major role of the latter in the lym-
phocyte mediated responses. However, in four patients the proportion of B-lymphocytes
exceeded 10% of all leukocytes. Based on a recent study [27], also B-lymphocytes may have a sig-
nificant role in the pathogenesis of ARMD, at least in some patients as discussed below.
The present results show that macrophage-dominated ARMD was typical for those patients
who had higher blood metal ion concentrations. This suggests that the metal debris induces
cytotoxicity or other phenomena that attract macrophages to the pseudotumor tissue. Cobalt-
chromium alloys are especially hard, but some amounts of chromium and cobalt particles or
soluble metal are released from hip devices by the wear or corrosion of the implant [32]. This is
reflected as increased chromium and cobalt concentrations in the circulation [28–30,33,34] as
also detected in the present study. In contrast to the micrometer-sized wear debris particles
produced by polyethylene bearings, the wear particles of MOM articulations have been found
to be primarily less than 50 nm in size [35,36]. The physiochemical and biological corrosion
also results in the release of soluble metal ions, from the larger particles and from the devices,
and the blood metal concentrations depict the concentrations of soluble metal ions surround-
ing the MOM device [37].
Activated macrophages phagocytize wear particles, which in the case of ARMD is evidenced
by metal particles within the cells [23,26,32]. Cobalt and chromium ions can also be trans-
ported into different cell types via non-specific anion carriers. Inside the cells, both cobalt and
chromium can induce the formation of reactive oxygen species, DNA and chromosome dam-
age, and cytotoxicity. [32,38] In vitro studies show that cobalt is more toxic than chromium:
cobalt nanoparticles have been reported to induce direct cell death at concentrations of 1 x 1012
particles/ml and cobalt ions at concentrations of 1000 μM [39]. Based on electron microscopic
examinations, cobalt cytotoxicity is associated with damage in mitochondria and cellular mem-
branes as well as disruption of cellular metabolism [39,40].
Furthermore, cobalt is known to induce cellular changes mimicking hypoxia, mainly
through enhancing the levels of transcription factor hypoxia inducible factor 1 alpha (HIF-1α)
[41,42]. Therefore it is likely that cobalt ions released fromMOM devices induce inflammatory
reactions and cytotoxicity typical for hypoxia. In support, it was recently reported based on
immunohistochemical staining that HIF-1α levels were increased in the peri-implant tissue of
failed MOM implants as compared to that of failed MOP implants [43]. Further, enhanced
HIF-1α expression was associated with increased production of reactive oxygen species and the
inflammatory cytokine TNFα. Cobalt ions may also have a direct stimulatory effect on macro-
phages. Tyson-Capper and co-workers [44] reported recently, by using reporter cell line, that
cobalt ions directly activated toll-like receptor 4 (TLR4). TLR4 is widely expressed in macro-
phages and has a significant role in triggering innate immune responses following exposure to
e.g. lipopolysaccharide and other bacterial products.
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The data described above give a potential explanation to our present finding that high blood
cobalt and chromium concentrations are associated with macrophage-dominated inflamma-
tory response in the pseudotumor tissue around failed MOM hips. Taken together, we hypoth-
esize that high blood metal levels reflect high peri-implant tissue levels of nanometer-sized
metal particles and metal ions, especially cobalt, which cause tissue injury and cell necrosis
around MOM hips. The damaged tissue recruits macrophages, which are the professional cells
to phagocytize necrotic cells and clean the tissue debris. This assumption is supported by the
histological finding that macrophages in the pseudotumor tissue contain small droplike inclu-
sions which resemble phagocytized organic material but not implant-derived wear debris [7].
In addition, the macrophages infiltrated into the peri-implant tissue are further activated by
the metal nanoparticles and soluble metal ions released locally from the MOM devices. That
further magnifies the inflammatory reaction in the pseudotumor tissue, e.g. through increased
production of proinflammatory cytokines IL-6 and TNFα as shown in the present study. This
sequence of events and the cytotoxic mechanisms of the metal debris and released metal ions
described above are proposed to form the basis of the pathogenesis of the macrophage-domi-
nated type of ARMD found in the present study.
A perivascular lymphocyte reaction is another characteristic feature in ARMD response
[7,20,23]. Our results suggest that the response is T-cell-dominated; and in about half of the
cases the T-lymphocyte accumulation is a predominant feature over the macrophage infiltra-
tion. According to the hypothesis of delayed hypersensitivity reaction, the metal ions released
from the implant can form complexes with tissue proteins and the aberrant metal-protein com-
plexes may be recognized by the immune system as foreign antigens and result in the activation
of the adaptive immune system. Lymphocyte infiltration into pseudotumor tissue supports this
hypothesis, but the results of hypersensitivity skin-tests performed to the patients with failure
of MOM implant have been contradictory [19,24,45–47]. However, it is challenging to establish
the connection between peri-implant tissue reaction and hypersensitivity measured by skin
tests since the immunological reactions evoked by transient cutaneous exposure to a pre-deter-
mined allergen may differ from that induced by the constant exposure to an orthopaedic
implant which may give rise to development of uncharacterized metal-modified endogenous
molecules [24,48]. Other methods to measure hypersensitivity, like lymphocyte transformation
test or migration test have still been only in a minor use [24]. In our study, when an inflamma-
tory pseudotumor reaction developed in patients who had only slightly increased whole blood
metal concentrations, the response showed T-lymphocyte-dominated phenotype. That points
primarily to metal-induced hypersensitivity reaction as the pathogenesis of the inflammatory
reaction around the hip arthroplasties rather than to metal-induced cytotoxicity.
In histological studies of ARMD, lymphocyte aggregates containing B-lymphocytes in addi-
tion to T-cells have been detected in a subpopulation of patients [7,27]; and this is supported
by the present finding that a quarter of our patients had moderate levels of B-lymphocytes. Fur-
thermore, the T and B-lymphocyte containing lymphoid aggregates were reported to display
features typical for tertiary lymphoid organs [27]. This finding suggests that also autoimmunity
to metal-carrier complexes may be involved in the pathogenesis of lymphocyte-dominated
ARMD [23,27].
After all, we hypothesize that high local metal concentrations in the pseudotumor tissue
result in cellular necrosis which recruits macrophages into the tissue to perform their basic
immunological function, i.e. to phagocytize necrotic cells and clean tissue debris. However, if
ARMD is developed in a situation where metal levels are only moderately elevated, delayed
hypersensitivity reaction characterized by dense accumulation of T-lymphocytes is a more
likely pathophysiological mechanisms. Metal sensitivity due to previous exposure e.g. to metal
containing medical devices or metal necklace is not uncommon in the population. In addition,
MOMReaction Is Linked to Blood Metal Levels
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susceptible individuals can develop delayed hypersensitivity reaction to altered metal-conju-
gated host proteins formed in the presence of MOM-released ions or nanoparticles. Also, auto-
immune mechanisms may contribute to the lymphocyte-mediated response. However, the
proposed hypothesis on the dominant role of the metal concentrations in the inflammatory
phenotype of ARMD needs to be further investigated since on the basis of our results, it is not
possible to conclude if these two inflammatory conditions are distinct from each other or if
they are interactive or consecutive processes. Also, the number of patients in our study was rel-
atively small.
In conclusion, the present results show that there are distinct inflammatory phenotypes
characterizing the adverse reaction to metal debris in patients with a failed ASR metal-on-
metal hip which may reflect different disease mechanisms. The macrophage-dominated
response was associated with higher blood metal ion concentrations and cytokines typical for
innate immune response. This is proposed to depict metal-induced cytotoxicity resulting in
massive macrophage infiltration and macrophage-mediated clearance of the necrotic tissue.
While ARMD reaction associated with lower metal concentrations was characterized by T-
lymphocyte-dominated tissue response applicable to hypersensitivity response.
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